25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Avita Therapeutics Inc
Buy, Hold or Sell?

Let's analyze Avita Therapeutics Inc together

I guess you are interested in Avita Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Avita Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Avita Therapeutics Inc

I send you an email if I find something interesting about Avita Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Avita Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Avita Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.15
Expected worth in 1 year
A$-0.90
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
A$-1.05
Return On Investment
-37.4%

For what price can you sell your share?

Current Price per Share
A$2.82
Expected price per share
A$2.45 - A$4.52
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Avita Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
A$2.82
Intrinsic Value Per Share
A$-10.16 - A$-5.01
Total Value Per Share
A$-10.01 - A$-4.86

2.2. Growth of Avita Therapeutics Inc (5 min.)




Is Avita Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$12.2m$110.2m-$80.8m-274.9%

How much money is Avita Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$14.3m-$12.6m-$1.6m-11.4%
Net Profit Margin-100.5%-91.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Avita Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#210 / 311

Most Revenue
#157 / 311

Most Profit
#262 / 311

Most Efficient
#233 / 311
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Avita Therapeutics Inc?

Welcome investor! Avita Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Avita Therapeutics Inc.

First you should know what it really means to hold a share of Avita Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Avita Therapeutics Inc is A$2.82. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avita Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avita Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.15. Based on the TTM, the Book Value Change Per Share is A$-0.26 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avita Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.12-4.4%-0.11-3.9%-0.06-2.3%-0.08-2.8%-0.06-2.2%
Usd Book Value Change Per Share-0.09-3.2%-0.16-5.8%-0.08-2.7%0.00-0.1%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.09-3.2%-0.16-5.8%-0.08-2.7%0.00-0.1%0.000.1%
Usd Price Per Share1.89-2.30-2.45-2.39-1.23-
Price to Earnings Ratio-3.79--6.19--9.23--9.41--4.56-
Price-to-Total Gains Ratio-21.03--18.84--38.85--15.42--9.88-
Price to Book Ratio20.10-11.95-2.98-4.71-2.84-
Price-to-Total Gains Ratio-21.03--18.84--38.85--15.42--9.88-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.764192
Number of shares566
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.160.00
Usd Total Gains Per Share-0.160.00
Gains per Quarter (566 shares)-93.27-1.42
Gains per Year (566 shares)-373.09-5.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-373-3830-6-16
20-746-7560-11-22
30-1119-11290-17-28
40-1492-15020-23-34
50-1865-18750-28-40
60-2239-22480-34-46
70-2612-26210-40-52
80-2985-29940-45-58
90-3358-33670-51-64
100-3731-37400-57-70

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%1.050.038.01.1%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%6.013.01.030.0%13.019.08.032.5%31.045.013.034.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.089.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%6.013.01.030.0%13.019.08.032.5%31.045.013.034.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Avita Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.144-0.263+83%-0.122-15%-0.004-97%0.003-4765%
Book Value Per Share--0.1500.362-58%1.356-89%1.192-87%0.675-78%
Current Ratio--3.7296.037-38%6.810-45%10.299-64%8.089-54%
Debt To Asset Ratio--0.8490.701+21%0.182+367%0.236+260%0.213+298%
Debt To Equity Ratio--5.6292.892+95%0.224+2408%0.685+722%0.482+1069%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--282537914.400373058361.525-24%636685571.375-56%595995187.643-53%313765825.398-10%
Eps---0.199-0.176-12%-0.103-48%-0.125-37%-0.097-51%
Ev To Ebitda Ratio--infinfnan%-7.433nan%infnan%infnan%
Ev To Sales Ratio--2.2634.277-47%7.144-68%10.230-78%9.593-76%
Free Cash Flow Per Share---0.136-0.184+35%-0.147+9%-0.123-9%-0.085-37%
Free Cash Flow To Equity Per Share---0.123-0.055-56%-0.139+13%0.024-617%0.017-813%
Gross Profit Margin--1.0001.0000%2.017-50%1.551-36%1.495-33%
Intrinsic Value_10Y_max---5.012--------
Intrinsic Value_10Y_min---10.157--------
Intrinsic Value_1Y_max---0.364--------
Intrinsic Value_1Y_min---0.643--------
Intrinsic Value_3Y_max---1.199--------
Intrinsic Value_3Y_min---2.268--------
Intrinsic Value_5Y_max---2.161--------
Intrinsic Value_5Y_min---4.249--------
Market Cap366453360.000-7%392442960.000476909160.000-18%508096680.000-23%495784107.000-21%256349069.340+53%
Net Profit Margin---0.829-1.005+21%-0.915+10%-1.354+63%-5.285+538%
Operating Margin----0%-1.0140%-1.1800%-5.6230%
Operating Ratio--1.8702.178-14%2.153-13%2.435-23%6.723-72%
Pb Ratio18.768-7%20.09911.954+68%2.981+574%4.710+327%2.839+608%
Pe Ratio-3.540+7%-3.791-6.185+63%-9.234+144%-9.406+148%-4.564+20%
Price Per Share2.820-7%3.0203.670-18%3.910-23%3.815-21%1.973+53%
Price To Free Cash Flow Ratio-5.201+7%-5.570-5.279-5%-6.807+22%-15.546+179%-8.132+46%
Price To Total Gains Ratio-19.634+7%-21.026-18.838-10%-38.848+85%-15.419-27%-9.881-53%
Quick Ratio--2.1033.990-47%9.483-78%11.680-82%8.371-75%
Return On Assets---0.200-0.158-21%-0.095-52%-0.111-45%-0.206+3%
Return On Equity---1.325-0.671-49%-0.118-91%-0.221-83%-0.325-75%
Total Gains Per Share---0.144-0.263+83%-0.122-15%-0.004-97%0.003-4765%
Usd Book Value--12215025.36529412915.928-58%110273275.143-89%96883501.779-87%54903599.129-78%
Usd Book Value Change Per Share---0.090-0.165+83%-0.076-15%-0.003-97%0.002-4765%
Usd Book Value Per Share--0.0940.226-58%0.849-89%0.746-87%0.423-78%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--176755719.249233385310.970-24%398310493.452-56%372854589.389-53%196291900.369-10%
Usd Eps---0.125-0.110-12%-0.065-48%-0.078-37%-0.061-51%
Usd Free Cash Flow---11019197.659-14922870.810+35%-11988294.634+9%-9995659.959-9%-6907759.537-37%
Usd Free Cash Flow Per Share---0.085-0.115+35%-0.092+9%-0.077-9%-0.053-37%
Usd Free Cash Flow To Equity Per Share---0.077-0.034-56%-0.087+13%0.015-617%0.011-813%
Usd Market Cap229253222.016-7%245512315.776298354370.496-18%317865283.008-23%310162537.339-21%160371977.779+53%
Usd Price Per Share1.764-7%1.8892.296-18%2.446-23%2.387-21%1.234+53%
Usd Profit---16189129.471-14316215.526-12%-12686868.058-22%-12415350.582-23%-8349377.413-48%
Usd Revenue--19526857.42914995299.806+30%14704863.527+33%11186117.125+75%6011089.758+225%
Usd Total Gains Per Share---0.090-0.165+83%-0.076-15%-0.003-97%0.002-4765%
 EOD+3 -5MRQTTM+12 -23YOY+10 -265Y+4 -3210Y+7 -29

3.3 Fundamental Score

Let's check the fundamental score of Avita Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.540
Price to Book Ratio (EOD)Between0-118.768
Net Profit Margin (MRQ)Greater than0-0.829
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.103
Current Ratio (MRQ)Greater than13.729
Debt to Asset Ratio (MRQ)Less than10.849
Debt to Equity Ratio (MRQ)Less than15.629
Return on Equity (MRQ)Greater than0.15-1.325
Return on Assets (MRQ)Greater than0.05-0.200
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Avita Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.880
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Fundamental data was last updated by Penke on 2025-01-24 16:34:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Avita Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avita Therapeutics Inc to the Medical Devices industry mean.
  • A Net Profit Margin of -82.9% means that $-0.83 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avita Therapeutics Inc:

  • The MRQ is -82.9%. The company is making a huge loss. -2
  • The TTM is -100.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-82.9%TTM-100.5%+17.6%
TTM-100.5%YOY-91.5%-9.0%
TTM-100.5%5Y-135.4%+34.9%
5Y-135.4%10Y-528.5%+393.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-82.9%-6.6%-76.3%
TTM-100.5%-14.2%-86.3%
YOY-91.5%-14.5%-77.0%
5Y-135.4%-14.8%-120.6%
10Y-528.5%-14.5%-514.0%
4.3.1.2. Return on Assets

Shows how efficient Avita Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avita Therapeutics Inc to the Medical Devices industry mean.
  • -20.0% Return on Assets means that Avita Therapeutics Inc generated $-0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avita Therapeutics Inc:

  • The MRQ is -20.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.0%TTM-15.8%-4.2%
TTM-15.8%YOY-9.5%-6.2%
TTM-15.8%5Y-11.1%-4.7%
5Y-11.1%10Y-20.6%+9.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.0%-2.3%-17.7%
TTM-15.8%-3.0%-12.8%
YOY-9.5%-3.9%-5.6%
5Y-11.1%-2.8%-8.3%
10Y-20.6%-3.6%-17.0%
4.3.1.3. Return on Equity

Shows how efficient Avita Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avita Therapeutics Inc to the Medical Devices industry mean.
  • -132.5% Return on Equity means Avita Therapeutics Inc generated $-1.33 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avita Therapeutics Inc:

  • The MRQ is -132.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -67.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-132.5%TTM-67.1%-65.4%
TTM-67.1%YOY-11.8%-55.4%
TTM-67.1%5Y-22.1%-45.1%
5Y-22.1%10Y-32.5%+10.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-132.5%-2.9%-129.6%
TTM-67.1%-3.9%-63.2%
YOY-11.8%-4.1%-7.7%
5Y-22.1%-4.1%-18.0%
10Y-32.5%-5.0%-27.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Avita Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Avita Therapeutics Inc is operating .

  • Measures how much profit Avita Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avita Therapeutics Inc to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avita Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-101.4%+101.4%
TTM-5Y-118.0%+118.0%
5Y-118.0%10Y-562.3%+444.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.2%+13.2%
TTM--21.7%+21.7%
YOY-101.4%-12.8%-88.6%
5Y-118.0%-16.3%-101.7%
10Y-562.3%-15.2%-547.1%
4.3.2.2. Operating Ratio

Measures how efficient Avita Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.87 means that the operating costs are $1.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avita Therapeutics Inc:

  • The MRQ is 1.870. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.178. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.870TTM2.178-0.309
TTM2.178YOY2.153+0.025
TTM2.1785Y2.435-0.256
5Y2.43510Y6.723-4.288
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8701.288+0.582
TTM2.1781.302+0.876
YOY2.1531.324+0.829
5Y2.4351.360+1.075
10Y6.7231.304+5.419
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Avita Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Avita Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.73 means the company has $3.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avita Therapeutics Inc:

  • The MRQ is 3.729. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.037. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.729TTM6.037-2.308
TTM6.037YOY6.810-0.773
TTM6.0375Y10.299-4.261
5Y10.29910Y8.089+2.210
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7292.595+1.134
TTM6.0372.712+3.325
YOY6.8102.910+3.900
5Y10.2993.515+6.784
10Y8.0893.470+4.619
4.4.3.2. Quick Ratio

Measures if Avita Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avita Therapeutics Inc to the Medical Devices industry mean.
  • A Quick Ratio of 2.10 means the company can pay off $2.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avita Therapeutics Inc:

  • The MRQ is 2.103. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.990. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.103TTM3.990-1.886
TTM3.990YOY9.483-5.493
TTM3.9905Y11.680-7.690
5Y11.68010Y8.371+3.309
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1031.481+0.622
TTM3.9901.586+2.404
YOY9.4831.875+7.608
5Y11.6802.415+9.265
10Y8.3712.550+5.821
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Avita Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Avita Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avita Therapeutics Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.85 means that Avita Therapeutics Inc assets are financed with 84.9% credit (debt) and the remaining percentage (100% - 84.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avita Therapeutics Inc:

  • The MRQ is 0.849. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.701. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.849TTM0.701+0.148
TTM0.701YOY0.182+0.519
TTM0.7015Y0.236+0.465
5Y0.23610Y0.213+0.023
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8490.403+0.446
TTM0.7010.406+0.295
YOY0.1820.369-0.187
5Y0.2360.429-0.193
10Y0.2130.451-0.238
4.5.4.2. Debt to Equity Ratio

Measures if Avita Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avita Therapeutics Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 562.9% means that company has $5.63 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avita Therapeutics Inc:

  • The MRQ is 5.629. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.892. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ5.629TTM2.892+2.737
TTM2.892YOY0.224+2.667
TTM2.8925Y0.685+2.207
5Y0.68510Y0.482+0.203
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6290.580+5.049
TTM2.8920.623+2.269
YOY0.2240.548-0.324
5Y0.6850.644+0.041
10Y0.4820.717-0.235
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avita Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Avita Therapeutics Inc to the Medical Devices industry mean.
  • A PE ratio of -3.79 means the investor is paying $-3.79 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avita Therapeutics Inc:

  • The EOD is -3.540. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.791. Based on the earnings, the company is expensive. -2
  • The TTM is -6.185. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.540MRQ-3.791+0.251
MRQ-3.791TTM-6.185+2.394
TTM-6.185YOY-9.234+3.049
TTM-6.1855Y-9.406+3.221
5Y-9.40610Y-4.564-4.842
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-3.540-1.500-2.040
MRQ-3.791-1.755-2.036
TTM-6.185-2.155-4.030
YOY-9.234-3.169-6.065
5Y-9.406-2.530-6.876
10Y-4.564-2.133-2.431
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avita Therapeutics Inc:

  • The EOD is -5.201. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.570. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.279. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.201MRQ-5.570+0.369
MRQ-5.570TTM-5.279-0.291
TTM-5.279YOY-6.807+1.529
TTM-5.2795Y-15.546+10.267
5Y-15.54610Y-8.132-7.414
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-5.201-1.609-3.592
MRQ-5.570-1.982-3.588
TTM-5.279-2.233-3.046
YOY-6.807-5.173-1.634
5Y-15.546-3.418-12.128
10Y-8.132-4.863-3.269
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Avita Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 20.10 means the investor is paying $20.10 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Avita Therapeutics Inc:

  • The EOD is 18.768. Based on the equity, the company is expensive. -2
  • The MRQ is 20.099. Based on the equity, the company is expensive. -2
  • The TTM is 11.954. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD18.768MRQ20.099-1.331
MRQ20.099TTM11.954+8.145
TTM11.954YOY2.981+8.974
TTM11.9545Y4.710+7.244
5Y4.71010Y2.839+1.872
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD18.7682.110+16.658
MRQ20.0992.239+17.860
TTM11.9542.408+9.546
YOY2.9813.027-0.046
5Y4.7104.282+0.428
10Y2.8394.589-1.750
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Avita Therapeutics Inc.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Tax Provision  182192948553-97-45



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets81,051
Total Liabilities68,824
Total Stockholder Equity12,227
 As reported
Total Liabilities 68,824
Total Stockholder Equity+ 12,227
Total Assets = 81,051

Assets

Total Assets81,051
Total Current Assets63,925
Long-term Assets17,126
Total Current Assets
Cash And Cash Equivalents 18,639
Short-term Investments 25,766
Net Receivables 10,288
Inventory 6,229
Total Current Assets  (as reported)63,925
Total Current Assets  (calculated)60,922
+/- 3,003
Long-term Assets
Property Plant Equipment 12,931
Intangible Assets 590
Long-term Assets Other 3,605
Long-term Assets  (as reported)17,126
Long-term Assets  (calculated)17,126
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities17,141
Long-term Liabilities51,683
Total Stockholder Equity12,227
Total Current Liabilities
Accounts payable 4,187
Other Current Liabilities 1,308
Total Current Liabilities  (as reported)17,141
Total Current Liabilities  (calculated)5,495
+/- 11,646
Long-term Liabilities
Long term Debt 42,547
Capital Lease Obligations Min Short Term Debt3,079
Long-term Liabilities  (as reported)51,683
Long-term Liabilities  (calculated)45,626
+/- 6,057
Total Stockholder Equity
Total Stockholder Equity (as reported)12,227
Total Stockholder Equity (calculated)0
+/- 12,227
Other
Capital Stock3
Common Stock Shares Outstanding 26,218
Net Debt 23,908
Net Invested Capital 54,774
Net Working Capital 46,784
Property Plant and Equipment Gross 15,982



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302002-12-312002-03-312001-12-312001-09-302001-03-312000-12-312000-09-302000-03-311999-12-311998-12-311997-12-31
> Total Assets 
1,797
1,124
2,806
11,518
9,727
5,418
7,810
9,909
5,058
8,811
8,560
13,425
17,112
12,878
13,115
9,169
23,293
18,174
19,002
22,414
16,412
17,624
13,078
23,935
18,880
14,199
12,043
12,392
10,866
16,206
15,505
12,700
8,881
9,830
7,933
9,913
8,905
9,243
7,856
7,904
8,027
17,487
18,689
15,343
15,681
10,706
10,706
16,157
16,157
12,909
12,909
8,861
8,861
7,313
7,313
3,605
3,605
5,443
5,443
10,521
10,521
8,603
8,603
11,844
11,844
7,668
7,668
16,516
16,516
23,017
16,908
36,347
25,603
36,314
25,729
22,239
95,267
0
119,487
105,345
89,889
168,627
125,501
121,173
159,671
142,304
148,706
156,244
144,340
138,544
129,616
126,025
111,640
97,381
87,826
81,051
81,05187,82697,381111,640126,025129,616138,544144,340156,244148,706142,304159,671121,173125,501168,62789,889105,345119,487095,26722,23925,72936,31425,60336,34716,90823,01716,51616,5167,6687,66811,84411,8448,6038,60310,52110,5215,4435,4433,6053,6057,3137,3138,8618,86112,90912,90916,15716,15710,70610,70615,68115,34318,68917,4878,0277,9047,8569,2438,9059,9137,9339,8308,88112,70015,50516,20610,86612,39212,04314,19918,88023,93513,07817,62416,41222,41419,00218,17423,2939,16913,11512,87817,11213,4258,5608,8115,0589,9097,8105,4189,72711,5182,8061,1241,797
   > Total Current Assets 
91
38
2,806
0
0
4,569
0
0
4,007
0
2,765
0
0
5,894
0
3,119
0
11,464
0
0
10,823
0
7,952
0
13,883
0
11,772
0
10,617
0
10,530
0
5,671
0
4,578
0
5,637
0
5,045
0
4,996
0
15,851
0
13,263
10,546
10,546
16,063
16,063
12,782
12,782
8,717
8,717
7,173
7,173
3,464
3,464
5,310
5,310
10,414
10,414
8,508
8,508
11,698
11,698
7,281
7,281
16,112
16,112
22,274
16,363
34,954
24,621
33,978
24,217
29,890
91,181
142,410
113,583
99,726
84,889
162,866
121,330
97,130
126,801
121,180
132,972
143,404
128,467
123,794
116,351
115,001
104,006
85,986
72,958
63,925
63,92572,95885,986104,006115,001116,351123,794128,467143,404132,972121,180126,80197,130121,330162,86684,88999,726113,583142,41091,18129,89024,21733,97824,62134,95416,36322,27416,11216,1127,2817,28111,69811,6988,5088,50810,41410,4145,3105,3103,4643,4647,1737,1738,7178,71712,78212,78216,06316,06310,54610,54613,263015,85104,99605,04505,63704,57805,671010,530010,617011,772013,88307,952010,8230011,46403,11905,894002,76504,007004,569002,8063891
       Cash And Cash Equivalents 
86
32
2,067
0
0
3,263
0
0
3,326
0
2,212
0
0
5,317
0
2,539
0
10,007
0
0
9,950
0
6,366
0
12,703
0
10,440
0
9,365
0
8,099
0
3,905
0
2,806
0
3,773
0
3,285
0
2,925
0
13,540
0
11,070
8,231
8,231
14,285
14,285
10,617
10,617
6,760
6,760
3,648
3,648
1,705
1,705
2,967
2,967
7,716
7,716
4,172
4,172
8,390
8,390
3,790
3,790
11,777
11,777
14,826
10,891
30,342
21,373
28,413
20,298
4,413
87,270
0
106,703
91,844
77,515
151,238
110,746
60,484
76,400
31,450
50,313
36,919
26,681
41,957
56,280
79,108
22,118
16,951
17,452
18,639
18,63917,45216,95122,11879,10856,28041,95726,68136,91950,31331,45076,40060,484110,746151,23877,51591,844106,703087,2704,41320,29828,41321,37330,34210,89114,82611,77711,7773,7903,7908,3908,3904,1724,1727,7167,7162,9672,9671,7051,7053,6483,6486,7606,76010,61710,61714,28514,2858,2318,23111,070013,54002,92503,28503,77302,80603,90508,09909,365010,440012,70306,36609,9500010,00702,53905,317002,21203,326003,263002,0673286
       Short-term Investments 
0
0
733
0
0
1,284
0
0
667
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
383
0
420
0
323
0
539
0
170
0
0
0
67
0
27
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
537
0
0
0
0
0
0
0
0
0
1,258
0
282
0
0
0
0
0
0
0
0
29,703
40,806
79,958
71,867
94,684
89,864
67,911
42,883
14,411
66,939
51,232
36,604
25,766
25,76636,60451,23266,93914,41142,88367,91189,86494,68471,86779,95840,80629,7030000000028201,25800000000053700000000000000000270670001700539032304200383000000000000000000000667001,2840073300
       Net Receivables 
5
6
5
777
30
11
18
20
5
35
376
335
703
529
294
205
440
343
1,076
971
711
844
627
586
462
853
723
388
340
1,131
1,082
723
506
657
530
548
492
953
810
1,086
1,103
1,298
1,387
1,262
1,290
1,462
959
1,152
1,152
1,215
773
835
835
2,547
497
905
905
1,505
651
991
991
2,022
659
1,897
1,897
2,071
170
2,491
2,491
5,437
3,994
3,302
1,787
681
2,087
2,972
2,081
2,507
3,524
3,296
3,250
7,214
7,403
3,721
3,426
5,563
6,115
6,793
5,187
7,506
9,303
9,452
7,664
7,081
8,717
10,288
10,2888,7177,0817,6649,4529,3037,5065,1876,7936,1155,5633,4263,7217,4037,2143,2503,2963,5242,5072,0812,9722,0876811,7873,3023,9945,4372,4912,4911702,0711,8971,8976592,0229919916511,5059059054972,5478358357731,2151,1521,1529591,4621,2901,2621,3871,2981,1031,0868109534925485306575067231,0821,1313403887238534625866278447119711,07634344020529452970333537635520181130777565
       Other Current Assets 
0
0
0
11
10
12
25
8
9
12
148
71
0
0
463
324
1,428
1,114
478
0
0
573
425
308
243
295
250
393
344
263
252
184
129
254
205
149
134
145
123
91
92
165
176
91
92
138
640
85
85
188
630
146
146
196
2,245
184
184
243
1,098
692
692
225
2,307
327
327
382
2,282
735
735
856
629
797
656
201
1,091
0
1
324
1,726
2,271
1,154
2,051
1,333
1,129
201
1,800
1,748
1,943
3,613
2,215
3,294
5,221
0
0
0
0
00005,2213,2942,2153,6131,9431,7481,8002011,1291,3332,0511,1542,2711,726324101,0912016567976298567357352,2823823273272,3072256926921,0982431841842,245196146146630188858564013892911761659291123145134149205254129184252263344393250295243308425573004781,1141,4283244630071148129825121011000
   > Long-term Assets 
1,706
1,086
0
0
0
292
0
0
5
0
5,795
0
0
6,983
0
6,050
0
6,710
0
0
5,589
0
5,125
0
4,997
0
271
0
249
0
4,975
0
3,210
0
3,355
0
3,268
0
2,811
0
3,032
0
2,838
0
2,418
160
160
93
93
127
127
144
144
140
140
141
141
133
133
106
106
94
94
145
145
387
387
404
404
743
545
1,394
982
2,160
1,512
0
4,086
0
5,905
5,619
5,000
5,761
4,171
24,043
31,574
21,124
15,734
12,839
15,873
14,750
13,265
11,025
7,634
11,395
14,868
17,126
17,12614,86811,3957,63411,02513,26514,75015,87312,83915,73421,12431,57424,0434,1715,7615,0005,6195,90504,08601,5122,1609821,394545743404404387387145145949410610613313314114114014014414412712793931601602,41802,83803,03202,81103,26803,35503,21004,9750249027104,99705,12505,589006,71006,05006,983005,79505002920001,0861,706
       Property Plant Equipment 
0
0
0
3
10
6
11
11
5
10
195
377
400
301
277
193
726
566
639
764
560
540
401
471
371
320
271
284
249
388
371
283
198
155
125
140
126
113
96
96
97
70
75
86
87
87
87
93
93
127
127
144
144
140
140
141
141
133
133
106
106
94
94
145
145
387
387
404
404
743
545
1,300
916
1,844
1,288
5,330
3,731
3,710
5,376
4,980
4,258
4,321
2,938
3,067
3,862
3,402
3,551
3,526
3,013
4,709
4,878
6,952
4,317
7,572
10,962
12,931
12,93110,9627,5724,3176,9524,8784,7093,0133,5263,5513,4023,8623,0672,9384,3214,2584,9805,3763,7103,7315,3301,2881,8449161,3005457434044043873871451459494106106133133141141140140144144127127939387878786757097969611312614012515519828337138824928427132037147140154056076463956672619327730140037719510511116103000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
12
12
12
12
12
0
0
0
0
0
0
19,801
0
11,684
6,743
4,012
6,930
4,189
2,754
0
0
0
0
0
000002,7544,1896,9304,0126,74311,684019,80100000012121212121200000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
452
513
286
128
0
0
0
5,544
9,382
8,880
6,682
8,377
5,857
7,874
6,144
7,372
6,869
5,030
6,367
4,724
5,864
4,626
0
0
0
0
4,412
4,221
4,107
2,872
3,803
3,069
3,498
3,143
3,194
2,714
2,889
2,934
2,585
2,763
2,280
2,331
73
73
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
94
66
317
225
14,278
355
0
527
563
545
610
472
472
610
556
620
702
683
690
685
714
487
542
545
590
590545542487714685690683702620556610472472610545563527035514,278225317669400000000000000000000000073732,3312,2802,7632,5852,9342,8892,7143,1943,1433,4983,0693,8032,8724,1074,2214,41200004,6265,8644,7246,3675,0306,8697,3726,1447,8745,8578,3776,6828,8809,3825,544000128286513452000
       Long-term Assets Other 
1,706
1,086
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-39
0
0
0
0
0
0
0
0
0
0
-160
-160
-93
0
-127
0
-144
0
-140
0
-141
0
-133
0
-106
0
-94
0
-145
0
-387
0
-404
0
-743
0
-1,394
0
-2,160
178
0
5,837
0
1
77
197
831
761
703
-31,574
1,553
1,796
2,339
1,998
3,086
3,567
3,359
2,527
2,995
3,067
3,605
3,6053,0672,9952,5273,3593,5673,0861,9982,3391,7961,553-31,57470376183119777105,8370178-2,1600-1,3940-7430-4040-3870-1450-940-1060-1330-1410-1400-1440-1270-93-160-1600000000000-39000000000000000000000000000000001,0861,706
> Total Liabilities 
19
20
88
70
66
36
34
1,026
524
127
313
732
880
662
731
511
1,364
1,064
1,825
1,559
1,141
2,600
1,929
1,542
1,216
1,258
1,067
1,295
1,136
2,662
2,547
1,980
1,385
1,240
1,000
893
802
4,565
3,880
3,359
3,411
1,436
1,535
1,421
1,452
2,152
2,152
1,653
1,653
2,453
2,453
1,594
1,594
1,786
1,786
1,401
1,401
1,226
1,226
1,852
1,852
1,750
1,750
984
984
2,546
2,546
1,993
1,993
3,883
2,951
5,017
3,593
6,311
4,866
3,499
8,549
0
14,578
13,872
12,591
12,038
9,846
9,681
12,588
11,594
14,642
18,678
19,865
22,528
26,549
28,057
62,584
64,812
63,911
68,824
68,82463,91164,81262,58428,05726,54922,52819,86518,67814,64211,59412,5889,6819,84612,03812,59113,87214,57808,5493,4994,8666,3113,5935,0172,9513,8831,9931,9932,5462,5469849841,7501,7501,8521,8521,2261,2261,4011,4011,7861,7861,5941,5942,4532,4531,6531,6532,1522,1521,4521,4211,5351,4363,4113,3593,8804,5658028931,0001,2401,3851,9802,5472,6621,1361,2951,0671,2581,2161,5421,9292,6001,1411,5591,8251,0641,3645117316628807323131275241,02634366670882019
   > Total Current Liabilities 
19
20
88
70
66
36
34
1,027
524
127
238
732
880
662
731
511
1,364
1,064
1,825
1,559
1,141
2,600
1,929
1,542
1,216
1,258
1,067
1,295
1,136
2,226
2,130
1,782
1,246
1,172
946
893
802
1,215
1,033
1,347
1,368
1,436
1,535
1,421
1,452
2,152
2,152
1,653
1,653
2,453
2,453
1,594
1,594
1,786
1,786
1,401
1,401
1,226
1,226
1,852
1,852
1,750
1,750
984
984
2,546
2,546
1,993
1,993
3,883
2,853
5,017
3,534
6,311
4,401
8,477
5,935
7,709
11,170
10,783
10,211
9,302
7,390
7,053
12,588
8,682
11,422
14,874
15,707
17,181
20,734
18,412
13,199
11,862
13,787
17,141
17,14113,78711,86213,19918,41220,73417,18115,70714,87411,4228,68212,5887,0537,3909,30210,21110,78311,1707,7095,9358,4774,4016,3113,5345,0172,8533,8831,9931,9932,5462,5469849841,7501,7501,8521,8521,2261,2261,4011,4011,7861,7861,5941,5942,4532,4531,6531,6532,1522,1521,4521,4211,5351,4361,3681,3471,0331,2158028939461,1721,2461,7822,1302,2261,1361,2951,0671,2581,2161,5421,9292,6001,1411,5591,8251,0641,3645117316628807322381275241,02734366670882019
       Short-term Debt 
0
0
733
0
0
1,284
0
0
41
0
36
0
0
13
0
10
0
9
0
0
6
0
0
0
0
0
0
0
0
0
32
0
420
0
323
0
539
0
170
0
0
0
67
0
27
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
537
0
0
0
0
0
0
134
134
0
0
4,390
4,390
0
503
0
0
0
0
0
0
0
0
0
0
702
612
638
656
904
0
0
0
0
0000904656638612702000000000050304,3904,39000134134000000537000000000000000002706700017005390323042003200000000060090100130036041001,2840073300
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
134
134
0
0
4,390
4,390
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000004,3904,39000134134000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
11
5
70
1
36
0
28
14
0
77
248
0
570
433
303
0
686
0
1,438
1,053
2,491
1,273
1,438
1,134
1,204
381
1,281
1,123
736
705
1,745
1,220
316
255
853
766
366
311
1,299
1,320
676
722
1,348
1,377
1,006
1,006
1,500
1,500
972
972
1,362
1,362
441
441
1,293
1,293
611
611
1,577
1,577
1,027
1,027
851
851
990
990
1,740
1,740
272
200
4,483
3,158
2,698
476
3,716
2,601
4,333
6,279
4,987
3,623
4,789
3,120
2,439
3,727
3,203
3,614
4,875
4,410
5,612
5,761
4,696
3,793
4,477
4,155
4,187
4,1874,1554,4773,7934,6965,7615,6124,4104,8753,6143,2033,7272,4393,1204,7893,6234,9876,2794,3332,6013,7164762,6983,1584,4832002721,7401,7409909908518511,0271,0271,5771,5776116111,2931,2934414411,3621,3629729721,5001,5001,0061,0061,3771,3487226761,3201,2993113667668532553161,2201,7457057361,1231,2813811,2041,1341,4381,2732,4911,0531,43806860303433570024877014280361705110
       Other Current Liabilities 
19
-3
78
0
64
-36
34
918
171
127
48
305
863
-489
283
-105
1,351
-318
1,815
114
-969
110
-616
104
-1,052
55
305
14
-1,111
1,456
689
37
-1,194
447
436
40
-730
759
410
47
-1,271
761
91
73
-1,303
139
139
-1,348
-1,348
510
510
-1,131
-1,131
904
904
-1,185
-1,185
3
3
-1,301
-1,301
-304
-304
-718
-718
566
566
-1,488
-1,488
3,339
2,653
-3,950
376
914
3,925
64
2,830
16
-1,387
810
2,966
-276
1,150
2,175
5,134
2,276
4,195
5,124
6,888
5,956
9,213
9,019
338
217
230
1,308
1,3082302173389,0199,2135,9566,8885,1244,1952,2765,1342,1751,150-2762,966810-1,387162,830643,925914376-3,9502,6533,339-1,488-1,488566566-718-718-304-304-1,301-1,30133-1,185-1,185904904-1,131-1,131510510-1,348-1,348139139-1,3037391761-1,27147410759-73040436447-1,194376891,456-1,1111430555-1,052104-616110-9691141,815-3181,351-105283-4898633054812717191834-3664078-319
   > Long-term Liabilities 
0
11
5
0
0
36
0
0
55
0
75
0
0
582
0
313
0
696
0
0
1,058
0
1,273
0
1,134
0
381
0
1,123
0
418
0
139
0
55
0
766
0
2,847
0
2,043
0
722
0
1,377
0
1,030
0
1,559
0
887
0
1,215
0
415
0
1,058
0
803
0
1,148
0
1,152
0
613
0
761
0
1,357
0
99
0
58
0
466
0
2,614
0
3,408
3,088
2,380
2,736
2,456
2,628
0
2,912
3,220
3,804
4,158
5,347
5,815
9,645
49,385
52,950
50,124
51,683
51,68350,12452,95049,3859,6455,8155,3474,1583,8043,2202,91202,6282,4562,7362,3803,0883,40802,614046605809901,3570761061301,15201,148080301,058041501,215088701,55901,03001,377072202,04302,84707660550139041801,123038101,13401,27301,058006960313058200750550036005110
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
134
0
83
0
54
0
3,123
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000003,12305408301340000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
417
417
199
199
0
0
0
0
3,350
3,350
2,012
2,012
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
134
134
120
120
49
49
612
64
435
435
435
596
1,018
1,578
1,521
1,327
1,453
1,691
2,028
2,525
0
2,826
0
0
0
0
0
000002,82602,5252,0281,6911,4531,3271,5211,5781,01859643543543564612494912012013413400000000000000000000000000002,0122,0123,3503,350000019919941741700000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
488
613
564
0
441
378
315
0
0
0
0
0
0
0
0
000000003153784410564613488000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
1,778
1,104
3,045
10,999
9,358
5,212
7,565
8,910
4,548
8,729
8,246
12,693
16,232
12,215
12,383
8,658
21,930
17,111
17,177
20,855
15,271
15,024
11,148
22,393
17,664
12,941
10,976
11,096
9,730
13,544
12,958
10,720
7,496
8,590
6,932
9,020
8,103
4,678
3,976
4,545
4,616
16,051
17,154
13,923
14,229
4,987
8,554
10,916
14,504
9,735
10,455
6,654
7,268
4,840
5,527
1,478
2,204
3,587
4,217
8,189
8,668
5,156
6,853
9,276
10,860
2,588
5,122
11,459
14,523
14,208
13,957
24,038
22,011
-215,239
20,863
18,740
86,719
0
104,909
91,474
77,297
156,588
115,655
111,492
-324,697
130,710
134,064
137,566
124,475
116,016
103,067
97,969
49,056
32,569
23,915
12,227
12,22723,91532,56949,05697,969103,067116,016124,475137,566134,064130,710-324,697111,492115,655156,58877,29791,474104,909086,71918,74020,863-215,23922,01124,03813,95714,20814,52311,4595,1222,58810,8609,2766,8535,1568,6688,1894,2173,5872,2041,4785,5274,8407,2686,65410,4559,73514,50410,9168,5544,98714,22913,92317,15416,0514,6164,5453,9764,6788,1039,0206,9328,5907,49610,72012,95813,5449,73011,09610,97612,94117,66422,39311,14815,02415,27120,85517,17717,11121,9308,65812,38312,21516,23212,6938,2468,7294,5488,9107,5655,2129,35810,9993,0451,1041,778
   Common Stock
6,882
6,451
9,594
20,835
20,835
11,605
20,835
22,585
11,528
24,160
16,957
30,208
36,866
27,744
37,028
25,888
51,791
40,410
51,968
61,309
44,892
61,309
45,494
74,095
58,449
74,095
62,846
74,095
64,970
86,824
83,069
86,824
60,712
86,824
70,072
88,672
79,655
88,877
75,534
89,374
90,768
101,758
108,756
101,664
103,900
101,663
101,663
111,391
111,391
111,442
111,442
111,442
111,442
111,442
111,442
111,442
111,442
117,044
117,044
126,459
126,459
126,264
126,264
134,773
134,773
134,806
134,806
150,787
150,787
162,801
119,592
188,210
132,575
4
143,065
317,116
222,006
3
4
4
4
4
3
3
4
4
4
5
4
4
5
5
0
0
0
0
0000554454443344443222,006317,116143,0654132,575188,210119,592162,801150,787150,787134,806134,806134,773134,773126,264126,264126,459126,459117,044117,044111,442111,442111,442111,442111,442111,442111,442111,442111,391111,391101,663101,663103,900101,664108,756101,75890,76889,37475,53488,87779,65588,67270,07286,82460,71286,82483,06986,82464,97074,09562,84674,09558,44974,09545,49461,30944,89261,30951,96840,41051,79125,88837,02827,74436,86630,20816,95724,16011,52822,58520,83511,60520,83520,8359,5946,4516,882
   Retained Earnings -348,225-332,020-316,627-297,969-452,530-423,683-406,570-385,716-402,187-364,486-327,909-324,701-227,444-221,496-285,388-273,383-286,540-282,429-194,913-143,559-205,061-128,689-215,243-115,643-164,172-109,155-148,593-139,328-139,328-132,218-132,218-125,497-125,497-121,108-121,108-118,270-118,270-113,458-113,458-109,963-109,963-106,602-106,602-104,788-104,788-101,707-101,707-100,475-100,475-96,677-96,677-93,2340-95,2120-89,4500-74,1850-74,3040-65,6940-55,4030-72,9730-57,8090-54,3540-42,9360-36,3740-31,28500-25,0050-18,7590-17,17400-9,9370-7,63900-7,11100-6,549-5,347-5,104
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
332,484
335,417
336,668
337,995
339,825
342,400
343,769
347,192
0
0
0
0
0000347,192343,769342,400339,825337,995336,668335,417332,484000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
651
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,987
3,567
-10,916
2,278
-9,735
0
-6,654
0
-4,840
0
-1,478
0
-3,587
0
-8,189
0
-5,156
0
-9,276
0
-2,588
0
-11,459
0
-14,208
0
-24,038
0
215,239
900
11,815
0
8,146
375,530
366,564
339,926
431,084
328,889
330,734
324,697
448,218
487,630
528,455
499,169
512,162
516,135
540,092
0
0
0
0
0000540,092516,135512,162499,169528,455487,630448,218324,697330,734328,889431,084339,926366,564375,5308,146011,815900215,2390-24,0380-14,2080-11,4590-2,5880-9,2760-5,1560-8,1890-3,5870-1,4780-4,8400-6,6540-9,7352,278-10,9163,567-4,98700000000000000000000000000000000000065100000000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.